Michael Sticherling (M Sticherling)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Topics

Atopic Dermatitis

Top Venues

The British journal of dermatology

American journal of clinical dermatology

Dermatology and therapy

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Sticherling, Arjen F Nikkels, Ashraf M Hamza, Pearl Kwong, Jacek C Szepietowski, Mahira El Sayed, Pierre-Dominique Ghislain, Alkes A Khotko, Manmath Patekar, Christine-Elke Ortmann, Pascal Forrer, Philemon Papanastasiou, Deborah Keefe
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials. American journal of clinical dermatology (2023)
Dora V Stölzl, Nicole Sander, Annice Heratizadeh, Eva Haufe, Inken Harder, Susanne Abraham, Luise Heinrich, Andreas Kleinheinz, Andreas Wollenberg, Elke Weisshaar, Knut Schäkel, Konstantin Ertner, Franca Wiemers, Julia Wildberger, Margitta Worm, Ralph von Kiedrowski, Isaak Effendy, Andrea Asmussen, Matthias Augustin, Mario Pawlak, Michael Sticherling, Alexander Zink, Melanie Hilgers, Christiane Handrick, Sven Quist, Beate Schwarz, Petra Staubach-Renz, Magnus Bell, Sun-Hei Hong-Weldemann, Bernhard Homey, Jens-Joachim Brücher, Jochen Schmitt, Thomas Werfel, Stephan Weidinger, null null
Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry. The British journal of dermatology 187 (6) (2022)
Laura Rechtien, Cornelia Erfurt-Berge, Michael Sticherling
SCLE manifestation after mRNA COVID-19 vaccination. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (4) (2022)
Roland Aschoff, Anthony Bewley, Annunziata Dattola, Clara De Simone, Mourad Lahfa, Mar Llamas Velasco, Antonio Martorell, Mira Pavlovic, Michael Sticherling
Beyond-Mild Psoriasis: A Consensus Statement on Calcipotriol and Betamethasone Dipropionate Foam for the Topical Treatment of Adult Patients. Dermatology and therapy 11 (5) (2021)
Susanne Abraham, E Haufe, I Harder, Annice Heratizadeh, A Kleinheinz, Andreas Wollenberg, E Weisshaar, Matthias Augustin, F Wiemers, Alexander Zink, Tilo Biedermann, R von Kiedrowski, M Hilgers, Margitta Worm, M Pawlak, Michael Sticherling, I Fell, C Handrick, Knut Schäkel, P Staubach, A Asmussen, B Schwarz, M Bell, K Neubert, I Effendy, Thomas Bieber, B Homey, B Gerlach, E Tchitcherina, M Stahl, U Schwichtenberg, J Rossbacher, P Buck, M Mempel, S Beissert, Thomas A Werfel, Stephan Weidinger, J Schmitt, null null
Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany. The British journal of dermatology 183 (2) (2020)
D Thaçi, A Pinter, M Sebastian, C Termeer, Michael Sticherling, S Gerdes, S Wegner, S Krampe, H Bartz, C Rausch, A Mensch, K Eyerich
Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS). The British journal of dermatology 183 (2) (2020)
Kristian Reich, A Körber, Ulrich Mrowietz, Michael Sticherling, C Sieder, J Früh, T Bachhuber
Secukinumab 2-weekly vs. 4-weekly dosing in patients with plaque-type psoriasis: results from the randomized GAIN study. The British journal of dermatology 184 (5) (2020)
Maike M Holtsche, S Goletz, N van Beek, D Zillikens, S Benoit, K Harman, S Walton, J English, Michael Sticherling, A Chapman, N J Levell, R Groves, H C Williams, I R König, Enno Schmidt, null null
Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score. The British journal of dermatology 179 (4) (2018)
Michael Sticherling, A Franke, E Aberer, R Gläser, M Hertl, C Pfeiffer, B Rzany, S Schneider, I Shimanovich, T Werfel, A Wilczek, D Zillikens, Enno Schmidt
An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone. The British journal of dermatology 177 (5) (2017)
Michael Sticherling, U Mrowietz, Matthias Augustin, D Thaçi, N Melzer, C Hentschke, J Kneidl, C Sieder, Kristian Reich
Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trial. The British journal of dermatology 177 (4) (2017)